Experimental Covid-19 pill shows promise in preliminary testing
The FDA has only approved one anti-viral drug for emergency use so far: Remdesivir. It’s been authorized to treat only people with severe Covid cases. Drugmaker Merck is now reporting promising results from a study that tested its experimental Covid pill. CNBC’s Meg Tirrell joins ‘The News with Shepard Smith’ to discuss.